Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab

• المؤلفون الرئيسيون: Greta Garrido (مؤلف), Ailem Rabasa (مؤلف), Cristina Garrido (مؤلف), Lisset Chao (مؤلف), Federico Garrido (مؤلف), Ángel M. García-Lora (مؤلف), Belinda Sánchez-Ramírez (مؤلف)
• التنسيق: كتاب
• منشور في: Frontiers Media S.A., 2017-10-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Defining how epidermal growth factor receptor (EGFR)-targeting therapies influence the immune response is essential to increase their clinical efficacy. A growing emphasis is being placed on immune regulator genes that govern tumor - T cell interactions. Previous studies showed an increase in HLA cl...